Apollon Formularies (AQSE:APOL) Liabilities-to-Assets : 0.47 (As of Jun. 2023)

Apollon Formularies Liabilities-to-Assets Chart

Apollon Formularies Annual Data
	Trend	Jun10	Jun11	Dec12	Dec13	Dec14	Dec17	Dec18	Dec19	Dec20	Dec21
Liabilities-to-Assets		Get a 7-Day Free Trial					0.32	0.31	0.41	0.04	0.03

Apollon Formularies Semi-Annual Data
	Jun11	Jun12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Jun23
Liabilities-to-Assets	Get a 7-Day Free Trial											0.04	0.04	0.03	0.17	0.47

Competitive Comparison of Apollon Formularies's Liabilities-to-Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Apollon Formularies's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Apollon Formularies's Liabilities-to-Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Apollon Formularies's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Apollon Formularies's Liabilities-to-Assets falls into.

Apollon Formularies Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Apollon Formularies's Liabilities-to-Assets Ratio for the fiscal year that ended in Dec. 2021 is calculated as:

Apollon Formularies's Liabilities-to-Assets Ratio for the quarter that ended in Jun. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apollon Formularies  (AQSE:APOL) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.

Apollon Formularies Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Apollon Formularies's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Apollon Formularies (AQSE:APOL) Business Description